Changes in red cell phosphate metabolism of preterm and fullterm infants with perinatal problems during their first

V Cholevas1, A Challa, P D Lapatsanis

  • 1Research Laboratory of Child Health Department, University of Ioannina, Medical School, P.O. Box 1186, Ioannina, 451 10, Greece. bcholev@cc.uoi.gr

Insights

Perinatal issues significantly delay phosphate metabolism in preterm infants, affecting red cell 2,3-DPG levels. Fullterm infants show different metabolic responses to these challenges.

Area of Science:

  • Neonatal physiology
  • Biochemistry
  • Perinatal medicine

Background:

  • Perinatal problems can impact infant metabolism.
  • Red blood cell (RBC) phosphate metabolism is crucial for oxygen delivery.

Purpose of the Study:

  • To investigate the effects of perinatal problems on red cell phosphate metabolism in preterm and fullterm infants during the first month of life.

Main Methods:

  • Comparison of plasma and RBC inorganic phosphate (Pi), 2,3-diphosphoglycerate (2,3-DPG), and ATP levels.
  • Study included two groups of infants: preterms and fullterms, each with and without perinatal problems.
  • Measurements were taken throughout the first month of life.

Main Results:

  • Preterm infants with perinatal problems showed delayed recovery of plasma and RBC Pi, and lower erythrocyte 2,3-DPG compared to controls.
  • Fullterm infants with perinatal problems had lower RBC Pi and ATP, but no significant difference in plasma Pi or RBC 2,3-DPG.
  • Fullterm infants with problems had higher plasma and RBC Pi than affected preterms.
  • RBC 2,3-DPG correlated with Pi levels in preterms and sick fullterms, but only with RBC Pi in healthy fullterms.

Conclusions:

  • Perinatal problems differentially affect phosphate metabolism in preterm and fullterm neonates.
  • These metabolic alterations may have implications for oxygen transport in vulnerable infants.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...